Negative Pressure Wound Therapy for Broken Leg
(iVAC Trial)
Trial Summary
What is the purpose of this trial?
This is a multi-center, pragmatic, parallel arm randomized controlled trial (RCT) of 352 patients with high-risk open or closed tibial plateau fracture, high-risk open or closed tibial pilon fracture, or open tibial shaft fracture with incision \>3cm. Eligible participants will be randomized to receive either incisional negative pressure wound therapy (NPWT) or a non-suction standard-of-care wound dressing for their definitive wound management. The primary outcome will be a composite outcome to evaluate clinical status 3 months after randomization. The secondary outcomes will independently assess the components of the primary outcome.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Incisional Negative Pressure Wound Therapy for broken legs?
Is negative pressure wound therapy safe for treating wounds?
How does Incisional Negative Pressure Wound Therapy differ from other treatments for broken leg wounds?
Incisional Negative Pressure Wound Therapy (INPWT) is unique because it uses a vacuum to help wounds heal by removing excess fluid and reducing swelling, which can prevent complications like infections. This method is different from traditional dressings that simply cover the wound without actively promoting healing.13101112
Research Team
I. Leah Gitajn, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
Renan Castillor, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria
This trial is for adults with specific high-risk fractures (like tibial plateau, pilon, or open tibial shaft) that have been treated surgically. Participants must have at least one wound primarily closed and be at risk of complications. Those with minor wounds or not requiring significant surgical intervention are excluded.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either incisional negative pressure wound therapy (NPWT) or a non-suction standard-of-care wound dressing
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Incisional Negative Pressure Wound Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Major Extremity Trauma Research Consortium
Lead Sponsor